Related Experiment Video

Updated: Jun 2, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Risks and benefits of multiple sclerosis therapies: need for continual assessment?

Bernd C Kieseier, Heinz Wiendl, Hans-Peter Hartung

    Current Opinion in Neurology
    |April 13, 2011
    PubMed
    Abstract

    Insights

    Balancing novel therapies for multiple sclerosis involves weighing increased clinical efficacy against potential serious side-effects. Careful risk-benefit assessment is crucial for optimizing patient outcomes and minimizing unnecessary risks.

    Area of Science:

    • Neurology
    • Pharmacology
    • Clinical Therapeutics

    Background:

    • Emerging novel therapies for relapsing multiple sclerosis (MS) present diverse mechanisms of action and administration routes.
    • These new treatments offer varying clinical benefits compared to established MS therapies.
    • A key challenge is the potential for heightened risks of serious side-effects with novel MS treatments.

    Discussion:

    • Physicians face the challenge of selecting optimal treatments based on limited experience with new therapies.
    • The decision-making process necessitates a thorough assessment of the risk-benefit profile for each therapeutic option.
    • Balancing enhanced clinical efficacy against potential adverse events is central to the ongoing debate in MS treatment.

    Key Insights:

    • Novel therapies for relapsing MS differ significantly in their efficacy, side-effect profiles, and administration methods.
    • Optimal patient care requires a careful evaluation of the trade-offs between treatment benefits and potential harms.
    • Physicians must navigate limited experience to make informed treatment choices for multiple sclerosis patients.

    Outlook:

    • Future treatment strategies will likely involve more personalized risk-benefit analyses.
    • Continued research is needed to better understand and manage the side-effect profiles of novel MS therapies.
    • Ensuring patients receive maximum benefit while avoiding unnecessary risks remains the primary goal for managing multiple sclerosis.

    More Related Videos

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

    Published on: September 9, 2022

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
    Drug Therapy01:28

    Drug Therapy

    The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
    Antianxiety Medications
    Therapeutic Drug Monitoring: Overview and Classification01:16

    Therapeutic Drug Monitoring: Overview and Classification

    Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
    Myocarditis IV: Nursing Management01:22

    Myocarditis IV: Nursing Management

    Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

    Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
    Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
    Therapeutic Drug Monitoring: Affecting Factors01:29

    Therapeutic Drug Monitoring: Affecting Factors

    Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.